{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T03:47:12Z","timestamp":1768448832023,"version":"3.49.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100016726","name":"Fondazione Aviralia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016726","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RF-2009-1539999"],"award-info":[{"award-number":["RF-2009-1539999"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["2012L783TW"],"award-info":[{"award-number":["2012L783TW"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.jcv.2018.04.001","type":"journal-article","created":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T14:15:25Z","timestamp":1522764925000},"page":"61-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Resistance detected in PBMCs predicts virological rebound in HIV-1 suppressed patients switching treatment"],"prefix":"10.1016","volume":"104","author":[{"given":"Daniele","family":"Armenia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5763-0650","authenticated-orcid":false,"given":"Mauro","family":"Zaccarelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanni","family":"Borghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Gennari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Di Carlo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Giannetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Forbici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ada","family":"Bertoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Gori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lavinia","family":"Fabeni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmela","family":"Pinnetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaella","family":"Marocco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Latini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Ceccherini-Silberstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio Maria","family":"Mastroianni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Mussini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Antinori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo Federico","family":"Perno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Mercedes","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2018.04.001_bib0005","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.coviro.2016.03.004","article-title":"Current status and prospects of HIV treatment","volume":"18","author":"Cihlar","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.jcv.2018.04.001_bib0010","series-title":"Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents","author":"Department of Health and Human Services","year":"2016"},{"key":"10.1016\/j.jcv.2018.04.001_bib0015","series-title":"Guidelines for the Clinical Management and Treatment of HIV Infected Adults in Europe. Version 9.0","author":"European AIDS Clinical Society (EACS)","year":"2017"},{"key":"10.1016\/j.jcv.2018.04.001_bib0020","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/15284336.2015.1115585","article-title":"Clinical outcomes of virologically-suppressed patients with pre-existing HIV-1 drug resistance mutations switching to rilpivirine\/emtricitabine\/tenofovir disoproxil fumarate in the SPIRIT study","volume":"17","author":"Porter","year":"2016","journal-title":"HIV Clin. Trials"},{"key":"10.1016\/j.jcv.2018.04.001_bib0025","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/jac\/dkq544","article-title":"Historical HIV-RNA resistance test results are more informative than proviral DNA genotyping in cases of suppressed or residual viraemia","volume":"66","author":"Wirden","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jcv.2018.04.001_bib0030","first-page":"1","article-title":"Usefulness of an HIV DNA resistance genotypic test in patients who are candidates for a switch to the rilpivirine\/emtricitabine\/tenofovir disoproxil fumarate combination","author":"Lambert-Niclot","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jcv.2018.04.001_bib0035","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/QAI.0b013e3180315515","article-title":"Genotypic resistance of archived and circulating viral strains in the blood of treated HIV-infected individuals","volume":"44","author":"Turriziani","year":"2007","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.jcv.2018.04.001_bib0040","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/QAI.0b013e3181a5b247","article-title":"The importance of testing genotypic resistance in proviral DNA of patients fully responding to highly active antiretroviral therapy","volume":"51","author":"Palmisano","year":"2009","journal-title":"JAIDS J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.jcv.2018.04.001_bib0045","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jcv.2016.07.007","article-title":"Genotypic resistance test in proviral DNA can identify resistance mutations never detected in historical genotypic test in patients with low level or undetectable HIV-RNA","volume":"82","author":"Zaccarelli","year":"2016","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2018.04.001_bib0050","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1093\/cid\/ciu020","article-title":"Reliability and clinical relevance of the HIV-1 drug resistance test in patients with low viremia levels","volume":"58","author":"Santoro","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jcv.2018.04.001_bib0055","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jcv.2009.10.012","article-title":"Magnetic-silica based nucleic acid extraction for Human Immunodeficiency Virus Type-1 drug-resistance testing in low viremic patients","volume":"47","author":"Milia","year":"2010","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2018.04.001_bib0060","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1093\/jac\/dkv029","article-title":"HIV-1 integrase genotyping is reliable and reproducible for routine clinical detection of integrase resistance mutations even in patients with low-level viraemia","volume":"70","author":"Armenia","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jcv.2018.04.001_bib0065","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1080\/14740338.2017.1343300","article-title":"Dual antiretroviral therapy for HIV infection","volume":"16","author":"Soriano","year":"2017","journal-title":"Expert Opin. Drug Saf."},{"issue":"3","key":"10.1016\/j.jcv.2018.04.001_bib0070","first-page":"855","article-title":"Pre-existent NRTI and NNRTI resistance impacts on maintenance of virological suppression in HIV-1-infected patients who switch to a tenofovir\/emtricitabine\/rilpivirine single-tablet regimen","volume":"72","author":"Armenia","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"issue":"Jan. (1)","key":"10.1016\/j.jcv.2018.04.001_bib0075","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/jac\/dkw368","article-title":"Less-drug regimen including atazanavir in maintenance treatment of HIV infection: how, who, when, why?","volume":"72","author":"Calvez","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jcv.2018.04.001_bib0080","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2174\/1570162X13666150407142539","article-title":"HIV replication at low copy number and its correlation with the HIV reservoir: a clinical perspective","volume":"13","author":"Sarmati","year":"2015","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.jcv.2018.04.001_bib0085","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1128\/CMR.00015-16","article-title":"Total HIV-1 DNA, a marker of viral reservoir dynamics with clinical implications","volume":"29","author":"Avettand-F\u00e8no\u00ebl","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.jcv.2018.04.001_bib0090","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev-genom-091212-153406","article-title":"Deep sequencing of HIV: clinical and research applications","volume":"15","author":"Chabria","year":"2014","journal-title":"Annu. Rev. Genomics Hum. Genet."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653218300921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653218300921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T03:10:05Z","timestamp":1761361805000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653218300921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":18,"alternative-id":["S1386653218300921"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2018.04.001","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resistance detected in PBMCs predicts virological rebound in HIV-1 suppressed patients switching treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2018.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}